NCT00367822View on ClinicalTrials.gov

Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

Not specified

Conditions
Restless Legs Syndrome
Interventions
DRUG

Lisuride

DRUG

Ropinirole

DRUG

Placebo

Trial Locations (1)

Unknown

IMEREM GmbH, Nuremberg

Sponsors

Lead Sponsor

Axxonis Pharma AG
All Listed Sponsors
lead

Axxonis Pharma AG

INDUSTRY